ChAd155-RG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ChAd155-RG, covering 2024-04-10 to 2024-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects [Phase 1]